Furthermore, CXCL13 increases the expression of EVT4 in pancreatic ductal adenocarcinoma (PDAC), and EVT4 promotes PDAC invasion and metastasis by binding to CXCR5 on the tumor cell surface (35). Here, CXCR5 is linked to neoplasm.